IMR Press / FBL / Volume 30 / Issue 2 / DOI: 10.31083/FBL33444
Open Access Opinion
How Histone Sensing Drives Alzheimer’s Disease
Show Less
Affiliation
1 Department of Medical Technology, Shaoguan University, 512005 Shaoguan, Guangdong, China
*Correspondence: wu20227050@163.com (Jia-Ping Wu)
Front. Biosci. (Landmark Ed) 2025, 30(2), 33444; https://doi.org/10.31083/FBL33444
Submitted: 2 December 2024 | Revised: 19 December 2024 | Accepted: 31 December 2024 | Published: 18 February 2025
Copyright: © 2025 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

The human DNA double helix is wrapped around proteins known as histones, which play a critical role in regulating gene expression. The goal of this opinion piece is to provide an overview of how histone sensing drives Alzheimer’s disease (AD). Histones are proteins enriched in basic amino acids. Histone acetylation plays an important role in the progression of AD as its dysregulation can lead to neuroinflammation and neurodegenerative diseases. Specifically, abnormal histone acetylation, a post-translation modification, is a key factor in AD as it contributes to brain cell inflammatory pathology. Thus, higher levels of histone acetylation could potentially serve as important biomarkers for the progression of AD. Here, we report that increased levels of acetylation of histones H2B, H3, and H4 in the promoter regions of Tip60 lysine acetyltransferase protein, p300/CREB-binding protein (CBP), GCN5-related N-acetyltransferases, p300/CBP-associated factor, elongator protein 3, brain-derived neurotrophic factor, and Tau genes in the hippocampus and temporal lobe are associated with the development of AD-associated learning and memory impairment.

Keywords
histone
Alzheimer’s disease
impaired learning
memory
histone acetylation
neuroinflammation
Figures
Fig. 1.
Share
Back to top